Article Sidebar

PDF
Date Published: 31/08/2023
Online Published: 31/07/2023
Abstract Views: 370
Views PDF: 251
DOI: https://doi.org/10.58490/ctump.2023i62.1271
Issue
No. 62 (2023)
Section
Article
How to Cite
Nguyen, H. T., Nguyen, T. L., Nguyen, T. T. H., & Dang, D. K. (2023). STUDY ON THE SAFETY AND APPROPRIATENESS OF PROTON PUMP INHIBITOR UTILIZATION IN OUTPATIENT PATIENTS RECEIVING MEDICAL SERVICES AT THE DEPARTMENT OF OUTPATIENT EXAMINATION, CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL IN 2022 - 2023. Cantho Journal of Medicine and Pharmacy, 62, 223-230. https://doi.org/10.58490/ctump.2023i62.1271

STUDY ON THE SAFETY AND APPROPRIATENESS OF PROTON PUMP INHIBITOR UTILIZATION IN OUTPATIENT PATIENTS RECEIVING MEDICAL SERVICES AT THE DEPARTMENT OF OUTPATIENT EXAMINATION, CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL IN 2022 - 2023

Huu Truc Nguyen1, Nguyễn Thanh Liêm1, Nguyễn Thị Thu Hiền1, Đặng Duy Khánh1,
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: In order to optimize treatment effectiveness, it is necessary to determine the current situation and assess the safety and appropriateness of proton pump inhibitors medication utilization. Objectives: To describe the characteristics and evaluate the safety and appropriateness of PPI medication use in outpatients at the Department of Clinical Examination, Can Tho University of Medicine and Pharmacy in 2022-2023. Materials and methods: 520 outpatient prescriptions for PPI medication at the Department of Clinical Examination, Can Tho University of Medicine and Pharmacy from September 2022 to April 2023. Assessing the appropriateness is based on the manufacturer's instructions and treatment protocols provided by the Ministry of Health. The determination of safety is established through the examination of drug interactions using two resources, Drugs.com and Medscape.com. Results: The highest proportion of PPI prescriptions was observed in the working age group of 18-59 years (63.85%), while the <18 age group had the lowest proportion (3.85%). Females had a higher prescription rate compared to males (59.23% and 40.77% respectively). The longest duration of both prescription and treatment with PPIs was ≥ 14 days was 78.65%. Esomeprazole was the most frequently prescribed PPI (46.92%), followed by Pantoprazole (22.31%), and Lansoprazole had the lowest proportion (0.39%). The proportion of prescriptions with drug interactions was 15.96%, inappropriate PPI prescriptions accounted for 8.56%, unsafe prescriptions were 15.19%, and the combination of inappropriate and unsafe prescriptions reached 20.77%.  Conclusion: The rate of inappropriate and unsafe use of PPI medications is quite high. This can have an impact on the effectiveness and cost of treatment. Enhancing communication and drug information is necessary to ensure effective treatment, safe medication usage, and cost savings for patients. 

Article Details

Author Biographies

Huu Truc Nguyen, Can Tho University of Medicine and Pharmacy

 

 

Nguyễn Thanh Liêm, Can Tho University of Medicine and Pharmacy

 

 

Nguyễn Thị Thu Hiền, Can Tho University of Medicine and Pharmacy

 

 

Đặng Duy Khánh, Can Tho University of Medicine and Pharmacy

 

 

Keywords

Proton pump inhibitors, outpatients, Can Tho University of Medicine and Pharmacy

References

1. Patel, D., Bertz, R., Ren, S. et al. A Systematic Review of Gastric Acid-Reducing AgentMediated Drug–Drug Interactions with Orally Administered Medications, Clin Pharmacokinet. 2020. 59, 447–462. https://doi.org/10.1007/s40262-019-00844-3.
2. Ottawa. Canadian Institute for Health Information. Drug Use Among Seniors in Canada. 2016. https://www.cihi.ca/en/drug-use-among-seniors-in-canada.
3. Wedemeyer, RS., Blume, H. Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update. Drug Saf. 2014. 37. 201–211. https://doi.org/10.1007/s40264-014-0144-0.
4. Susanna M. Wallerstedt et al. Long-term use of proton pump inhibitors and prevalence of disease- and drug-related reasons for gastroprotection - a cross-sectional population-based study. Pharmacoepidemiol Drug Saf. 2017. 26(1), pp.9-16. https://doi.org/10.1002/pds.4135.
5. Nguyễn Hoàng, Tình hình sử dụng thuốc ức chế bơm proton trong kê đơn thuốc bảo hiểm y tế ngoại trú tại bệnh viện đa khoa tỉnh sóc trăng năm 2020, Trường đại học Y Dược Cần Thơ. 2021. 38.
6. Hoàng Đức Thái, Nguyễn Hồng Ngọc. Đánh giá tình hình sử dụng thuốc ức chế bơm proton tại Bệnh viện Quân y 120 tỉnh Tiền Giang tháng 7/2020. Trường Đại học Tây Đô. 2020. 51-65.
7. Trần Thị Kim Thuẩn, Nguyễn Thị Linh Tuyền , Trần Thị Tuyết Phụng. Nghiên cứu tình hình kê đơn thuốc ức chế bơm proton trong điều trị ngoại trú tại trung tâm y tế huyện chợ gạo năm 2020. Tạp chí Y Dược học. 2021. 41, 22-23. https://tapchi.ctump.edu.vn/index.php/ctump/article/view/749.
8. Bùi Đặng Minh Trí, Bùi Đặng Phương Chi, Nguyễn Hồng Ngọc. Tính hợp lý trong sử dụng thuốc ức chế bơm proton (PPI). Tạp Chí Y học Cộng đồng. 2021. 62(3), 59-62. https://doi.org/10.52163/yhc.v62i3%20(2021).65
9. Huỳnh Tố Quyên. Khảo sát tình hình sử dụng và đánh giá hiệu quả của thuốc ức chế bơm proton trong bệnh lý loét dạ dày tá tràng tại Trung tâm y tế huyện Cù Lao Dung tỉnh Sóc Trăng năm 2021. Trường Đại học Tây Đô. 2022. 35-48.
10. Liu, L., Yu, Y., Fan, Q. et al. Impact of proton pump inhibitor management committee’s multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments. BMC Health Serv Res. 2022. 22, 417.
11. Phạm Huỳnh Thanh Trâm. Nghiên cứu tình hình sử dụng thuốc ức chế bơm proton cho bệnh nhân nội trú tại khoa Nội Bệnh viện Đa khoa tỉnh Sóc Trăng năm 2019-2020. Trường Đại học Y Dược Cần Thơ. 2020. 33-43.
12. Giannini EG, Crespi M, Djahandideh A, Demarzo MG, Moscatelli A, Bodini G, Furnari M, Marabotto E, Plaz Torres MC, Zentilin P, Savarino V. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation. Dig Liver Dis. 2020 Aug. 52(8). 862-868. https://doi.org/10.1016/j.dld.2020.05.005.
13. Çelik F, Aypak C, Özdemir A, Görpelioğlu S. Inappropriate Prescribing of Proton Pump Inhibitors in Outpatient Clinics. Gastroenterol Nurs. 2021 Mar-Apr 01. 44(2). 84-91. https://doi.org/10.1097/sga.0000000000000500.
14. Nguyễn Thị Thuý. Nghiên cứu tình hình và đánh giá kết quả sử dụng hợp lý, an toàn thuốc ức chế bơm proton trên người bệnh nội trú tại Trung tâm Y tế Thị xã Long Mỹ năm 20182019. Trường Đại học Y Dược Cần Thơ. 2019. 32-45.
15. Liu Y, Zhu X, Li R, Zhang J, Zhang F. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. BMJ Open. 2020 Nov 26.10(11):e040473. https://doi.org/10.1136/bmjopen-2020-040473